PFG
ROIV icon

Peterson Financial Group’s Roivant Sciences ROIV Stock Holding History

Peterson Financial Group’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$5.63K Buy
+488
New +$5.56K 0.02% 282

Other funds holding ROIV

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return

Peterson Financial Group's ROIV Position: Q3 2024 in Review

Peterson Financial Group opened a new position in Roivant Sciences (ROIV) in Q3 2024: 488 shares worth $5.63K. The stake represents 0.02% of the portfolio and ranks #282 among its holdings.

294 funds tracked by Wall St. Rank hold ROIV as of Q3 2024.

  • Peterson Financial Group held 488 shares of Roivant Sciences worth $5.63K as of Q3 2024.
  • Roivant Sciences was a new Peterson Financial Group position in Q3 2024.
  • Roivant Sciences made up 0.02% of Peterson Financial Group's portfolio in Q3 2024, its #282 holding.
  • 294 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2024.

Based on Peterson Financial Group's 13F filing for Q3 2024, filed 6 Nov 2024.